CTI 222 Pill — WHITE ROUND, 11mm — Ciprofloxacin
| Imprint | CTI / 222 |
|---|---|
| Colour | WHITE |
| Shape | ROUND |
| Size | 11 |
| Strength | CIPROFLOXACIN HYDROCHLORIDE 250 mg |
| Dosage form | Tablet, Film Coated |
| Manufacturer | PD-Rx Pharmaceuticals, Inc. |
| NDC | 72789-006 |
| Schedule | — |
| Availability | — |
| Ingredients | CIPROFLOXACIN HYDROCHLORIDE[CIPROFLOXACIN] |
What does this imprint mean?
The imprint "CTI 222" is a code stamped or printed on the tablet or capsule by the manufacturer, used to identify the drug, its strength and the maker.
Active ingredient
Ciprofloxacin
Uses and warnings
BOXED WARNING: BOXED WARNING: Fluoroquinolones including ciprofloxacin are "associated with disabling and potentially irreversible serious adverse reactions" including tendinitis/tendon rupture, peripheral neuropathy, and central nervous system effects occurring together. The drug may exacerbate muscle weakness in myasthenia gravis patients and should be avoided in that population. Key Warnings: - Discontinue immediately upon experiencing serious adverse reactions - Risk of tendon rupture (especially Achilles tendon), particularly in patients over 60, on corticosteroids, or with organ transplants - Peripheral neuropathy with potentially irreversible symptoms - CNS effects: psychiatric reactions, seizures, hallucinations, depression with suicidal ideation - Serious hypersensitivity/anaphylactic reactions possible - Hepatotoxicity including fatal hepatic failure reported - QT interval prolongation and torsade de pointes risk - Aortic aneurysm and dissection risk in elderly patients - C. difficile-associated diarrhea possible | BOXED WARNING: Fluoroquinolones including ciprofloxacin are "associated with disabling and potentially irreversible serious adverse reactions" including tendinitis/tendon rupture, peripheral neuropathy, and central nervous system effects occurring together. The drug may exacerbate muscle weakness in myasthenia gravis patients and should be avoided in that population. Key Warnings: - Discontinue immediately upon experiencing serious adverse reactions - Ris
Ciprofloxacin tablets are a fluoroquinolone antibacterial indicated in adults (18+ years) and select pediatric patients for treating infections including: skin/skin structure infections, bone and joint infections, complicated intra-abdominal infections, infectious diarrhea, typhoid fever, uncomplicated gonorrhea, inhalational anthrax post-exposure, plague, chronic bacterial prostatitis, lower respiratory tract infections, urinary tract infections, and acute sinusitis. The label emphasizes reserving use for patients with no alternative treatment options for certain conditions like acute uncomplicated cystitis and acute bronchitis exacerbations due to serious adverse risks.
How to identify this pill
- • Check the imprint matches exactly: "CTI 222".
- • Confirm the colour (WHITE) and shape (ROUND).
- • Compare the size (11) against a ruler if possible.
- • When in doubt, confirm with a pharmacist before taking any medication.
Similar-looking pills
227
WHITE ROUND · Metformin
HP 227
WHITE ROUND · Acyclovir
M E16
WHITE ROUND · Enalapril
E55
WHITE ROUND · Amlodipine
3969 WPI
WHITE ROUND · Metronidazole
ARI 20
WHITE ROUND · Aripiprazole
PLIVA 434
WHITE ROUND · Trazodone
TCL340
WHITE ROUND · Acetaminophen
WATSON 942
WHITE ROUND · Estradiol
TEVA 7272
WHITE ROUND · Pioglitazone
MP 58
WHITE ROUND · Carisoprodol
SYNTHROID 50
WHITE ROUND · Levothyroxine
Other pills of Ciprofloxacin
CR 250
WHITE ROUND · Ciprofloxacin
P 500
WHITE CAPSULE · Ciprofloxacin
P 500
WHITE CAPSULE · Ciprofloxacin
P 500
WHITE BULLET · Ciprofloxacin
WW929
WHITE CAPSULE · Ciprofloxacin
R 126
WHITE OVAL · Ciprofloxacin
C 94
WHITE CAPSULE · Ciprofloxacin
CR 250
WHITE ROUND · Ciprofloxacin
C 95
WHITE ROUND · Ciprofloxacin
TEVA 5312
WHITE OVAL · Ciprofloxacin
T92
WHITE ROUND · Ciprofloxacin
P 500
WHITE CAPSULE · Ciprofloxacin
Official references
Source: FDA Structured Product Label via NLM Pillbox archive (retired 2021); source file ae6c8fa2-cb3d-76cc-e053-2995a90ac968.xml